FAKTOR-OPTIONSSCHEIN - MEDTRONIC Share Price

Certificat

DE000SD41SG4

Real-time Boerse Frankfurt Warrants 04:28:17 27/06/2024 pm IST
0.044 EUR 0.00% Intraday chart for FAKTOR-OPTIONSSCHEIN - MEDTRONIC
Current month-12.00%
1 month-21.43%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
27/24/27 0.044 0.00%
26/24/26 0.044 -2.22%
25/24/25 0.045 -8.16%
24/24/24 0.049 -3.92%
21/24/21 0.051 +10.87%

Real-time Boerse Frankfurt Warrants

Last update June 27, 2024 at 04:28 pm IST

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying MEDTRONIC PLC
IssuerLogo Issuer Société Générale Société Générale
WKN SD41SG
ISINDE000SD41SG4
Date issued 29/03/2021
Strike 116.7 $
Maturity Unlimited
Parity 1 : 1
Emission price 8.59
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 15.67
Lowest since issue 0.03
Spread 0.01
Spread %18.52%

Company Profile

Medtronic plc is one of the world leaders in designing, manufacturing and marketing of medical equipment. Net sales break down by sector of activity as follows: - general and minimally invasive surgery (28.8%): surgical equipment, intra-operative monitoring systems, ventilation systems, etc.; - cardiac rhythm management (18.6%): implantable cardiac pacemakers, implantable defibrillators and automatic external defibrillators, cardiac ablation probes, etc.; - vascular diseases and cardiac surgery (17.4%): coronary stents, endoprostheses for aortal pathologies, distal protection systems, catheters, heart valve prostheses, auto-transfusion equipment, cardiac ablation devices, etc.; - spinal disorders (14.1%): spinal prostheses, disc prostheses, cerebral stimulation systems, bone graft technologies and mini-invasive spinal surgery, etc. The group also develops medical imagery-guided surgical navigation systems activity; - neurovascular, ear, nose and throat (ENT) and pelvic diseases (8.2%); - diabetes management (7.4%): internal and external glycemia monitoring systems and insulin pumps; - neurological disorders (5.5%): neurostimulation and pumped medication administration products, diagnostic tools, etc. Net sales are distributed geographically as follows: Ireland (0.3%), the United States (50.9%) and other (48.8%).
Sector
-
More about the company

Ratings for Medtronic plc

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings

Consensus: Medtronic plc

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
33
Last Close Price
80.05 USD
Average target price
94.02 USD
Spread / Average Target
+17.46%
Consensus